Identifying the Black Death

In just four years in the mid-fourteenth century, the medieval pandemic of 'Black Death' killed 17-28 million Europeans, or 30-40% of the total population. Further resurgences later in the century eliminated 90% of the households around Montpellier in southern France. It is in this region that Raoult et al. went searching for the causative agent of the Black Death. Although this agent has been presumed to be Yersinia pestis, the pattern of the disease's spread has led others to suggest alternati

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In just four years in the mid-fourteenth century, the medieval pandemic of 'Black Death' killed 17-28 million Europeans, or 30-40% of the total population. Further resurgences later in the century eliminated 90% of the households around Montpellier in southern France. It is in this region that Raoult et al. went searching for the causative agent of the Black Death. Although this agent has been presumed to be Yersinia pestis, the pattern of the disease's spread has led others to suggest alternative agents. In the November 7 Proceedings of the National Academy of Sciences, Raoult et al. use 'suicide' PCR to amplify DNA remnants of Yersinia pestis from tooth pulp, thus providing evidence that Yersinia was the agent of Black Death (Proc Natl Acad Sci USA 2000, 97:12800-12803). The teeth came from a grave that is dated to the time of the pandemic, and termed a 'catastrophe' grave because it contains ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies